期刊文献+

环氧合酶-1和环氧合酶-2基因多态性与阿司匹林抵抗的相关性研究 被引量:10

Correlation between cyclooxygenase-1,2 gene polymorphism and aspirin resistance
原文传递
导出
摘要 目的探讨环氧合酶-1(COX-1)、环氧合酶-2(COX-2)基因多态性与阿司匹林抵抗相关性。方法将96例缺血性脑卒中患者分为阿司匹林敏感组87例和阿司匹林非敏感组9例。2组患者口服100 mg阿司匹林至少一周。用光比浊法对患者的血小板聚集度进行测定,用Sequenom Mass A RRAY i PLEX基因型分析技术进行COX-1、COX-2的基因型检测,分析COX-1、COX-2基因多态性与阿司匹林的相关性。结果阿司匹林非敏感组患者的既往卒中史比例66.7%(6/9)显著高于阿司匹林敏感组21.9%(19/87)(P<0.05)。2组患者的COX-1(rs1330344,rs3842788)基因型分布差异有统计学意义(P<0.05),但COX-1(rs5788)、COX-2(rs20417)基因型分布差异无统计学意义(P>0.05)。COX-1(rs5788,rs1330344,rs3842788)、COX-2(rs20417)等位基因及基因型频率4个单核苷酸基因多态性均符合Hardy-Weinberg平衡(P>0.05)。结论 COX-1(rs3842788,rs1330344)GG型与阿司匹林抵抗密切相关。 Objective To investigate the correlation between cyclooxygenase- 1( COX- 1),cyclooxygenase- 2( COX- 2) gene polymorphism and aspirin resistance. Methods Ninety six patients with ischemic stroke were divided into aspirin- sensitive group( n = 87) and aspirin-insensitive group( n = 9). The patients in two groups were given 100 mg aspirin by oral administration forat least a week. Platelet aggregation was measured by light nephelometry genotypings of COX- 1,COX- 2 were detected by Sequenom Mass A RRAY i PLEX genotyping technology and the correlation of gene polymorphism and aspirin were analyzed. Results The previous history of stroke ratio of aspirin- insensitive group was66. 7%( 6 /9),significantly higher than that of aspirin- sensitive group( 21. 9%,19 /87)( P〈 0. 05) The COX- 1 genotypes( rs1330344,rs3842788) between two groups were significantly different( P 〉0. 05),but the difference of COX- 1( rs5788),COX- 2( rs20417) was not significant( P〉 0. 05). COX- 1( rs5788,rs1330344,rs3842788),COX- 2( rs20417),etc. allele and genotype frequencies of 4 SNPs were consistent with Hardy- Weinberg equilibrium( P 0. 05).Conclusion COX- 1( rs3842788,rs1330344) GG type is closely related to aspirin resistance.
作者 张斯时 张艳
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2015年第17期1724-1726,共3页 The Chinese Journal of Clinical Pharmacology
关键词 环氧合酶-1 环氧合酶-2 基因多态性 阿司匹林抵抗 相关性 cyclooxygenase-1 cyclooxygenase-2 gene polymorphism aspirin resistance correlation
  • 相关文献

参考文献3

二级参考文献36

  • 1Antithrombotic Trialists Collaboration. Collaborativemeta-an- alysis of randomized trims of antiplatelet therapy for preven- tion of death, myocardial infarction, and stroke in high risk patiems[ J]. BMJ,2002,324 (7329) :71-86.
  • 2JUUL-MOLLER S, EDVARDSSON N, JAHNMATZ B, et al. Double-blind trial of aspirin in primary prevention of myocar- dial infarction in patients with stable chronic angina pectoris [ J ]. Lancet, 1992,340 ( 8833 ) : 1421 - 1425.
  • 3LEE P Y, CHEN W H, NG W, et al. Low-dose aspirin increa- ses aspirin resistance in patients with coronary artery disease [J]. Am J Med,2005,118(7) :723-727.
  • 4GUM P A, KOTFKE-M K, POGGIO E D, et al. Profile and prevalence of aspirin resistance in patients with cardiovascu- lar disease [ J ]. Am J Cardio1,2001,88 ( 3 ) : 230-235.
  • 5PAPP E, HAVASI V, BENE J, et al. Glycoprotein Ⅲ A gene (P1A) polymorphism and aspirin resistance: is there any cor- relation? [ J ]. Ann Pharmacother, 2005,39 ( 6 ) : 1013-1018.
  • 6BHATY D L. Aspirin resistance:more than just a laboratory curiosity [ J ]. J Am Coil Cardio1,2004,43 (6) : 1127-1129.
  • 7Kuliczkowski W,Witkowski A,Polonski L,et al. Interindivid ual variability in the response to oral antiplatelet drugs:a po sition paper of the Working Group on Antiplatelet Drugs Re sistance appointed by the Section of Cardiovascular Interven tions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J,2009,30:426-435.
  • 8Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta analysis of individual participant data from randomised trials. Lancet, 2009,373 :1849 -1860.
  • 9Krasopoulos G, Brister SJ, Beattie WS, et al. Aspirin "resist ance" and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ, 2008,336 :195-198.
  • 10Agundez JA, Martinez C, Perez Sala D, et al. Pharmaccjg enomics in aspirin intolerance. Curr Drug Metab, 2009, 10: 998-1008.

共引文献16

同被引文献72

引证文献10

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部